|Previous Section||Index||Home Page|
Phil Hope: As announced in the written ministerial statement to the House on 8 October 2008, Official Report, column 17WS, Professor Ian Gilmore has been asked to lead a review of prescription charges on how to implement our plans to phase in free prescriptions for those people in England with long term conditions effectively. We expect to publish the findings of this review in summer 2009.
Mr. Laxton: To ask the Secretary of State for Health what plans the Advisory Committee on the Safety of Blood, Tissues and Organs has to undertake bacterial infection in blood trials as part of their comprehensive review of pathogen inactivation for blood products in 2009. 
Dawn Primarolo: Information from NHS Blood and Transplant trials including published literature on pathogen inactivation will be discussed as part of the independent Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) review on options to reduce the risk of bacterial infection in blood. SaBTO does not commission research of this type. The Department in conjunction with the UK Blood Services have commissioned relevant research, trials and efficacy studies, which are due to be completed before any intervention is presented to SaBTO for their consideration and subsequently implemented.
Harry Cohen: To ask the Secretary of State for Health (1) when information on incidence and mortality will be collected for people with breast cancer from black, Asian and other minority ethnic backgrounds; and if he will make a statement; 
(2) what the timeframe is for evaluating and agreeing models that collect data on prevalence of people with breast cancer from black, Asian and other minority ethnic backgrounds; and if he will make a statement. 
Ann Keen: Incidence and mortality data are already collected for all patients with cancer, and compiled through the regional cancer registries. The National Cancer Intelligence Network (NCIN) has cross-linked the most recent 10 years of complete data from hospital episode statistics (HES) to cancer registry data, which has enabled ethnicity data from HES to be assigned to cancer registry records. Using this linked repository, the NCIN will publish its first report on cancer incidence and mortality in relation to ethnicity in 2009.
The NCIN, working with Macmillan and the Thames Cancer Registry, published preliminary figures on cancer prevalence in July 2008 and a full report is due to be published in January 2009. Work to publish figures on prevalence by ethnicity will follow the NCIN report on cancer incidence and mortality in relation to ethnicity.
It is not possible to supply a figure for the number of nurses there are within the national health service working in breast care as this information is not
collected centrally. A break down of nurses by area of work is shown in the following tables.
|Table 3a: NHS hospital and community staff: qualified nursing, midwifery and health visiting staff by area of work 1996 to 2007, England as at 30 September each year|
|Table 3b: NHS HCHS: Qualified nursing, midwifery and health visiting staff by area of work 1996 to 2007, England as at 30 September each year|
1. Totals may not equal the sum of component parts due to rounding and the inclusion of unclassifiable staff.
2. More accurate validation this year means that in 2006 9,858 duplicate records were identified and removed from the non-medical census.
3. The impact of duplicates on full-time equivalent has been minimal with the removal of 507.
|Next Section||Index||Home Page|